Diabetes is a non-communicable disease (NCD). The World Health Organization estimates that 347 million people worldwide have diabetes, and that number is expected to continue increasing as more people move to urban cities and the population ages.
Low and middle-income countries, like China and India, have been hit hardest with this disease and other NCDs. In 2010, the total number of people with type 2 diabetes has been over 90 million in China, the country with the most diabetics worldwide.
To address the ever increasing burden of diabetes around the world, the Institute established a diabetes research program and appointed Professor JI Linong, Vice President of International Diabetes Federation and Ex-President of Chinese Diabetes Society as the Chief Scientist, coordinating diabetes research at The George Institute for Global Health.
The diabetes research program covers type 1 diabetes, type 2 diabetes and gestational diabetes, and includes a broad range of research focusing on epidemiology, treatment, behaviour change, health care system, and health economy. To date, it has been involved in nine diabetes research projects, including five large-scale clinical research studies such as ADVANCE. In China alone, over 25,000 patients have been involved in our different diabetes projects.